Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | ERN1 | O75460 | 1/20 | 0.42 |
| ▸ | QDPR | P09417 | 1/20 | 0.40 |
| ▸ | CDC7 | O00311 | 1/20 | 0.39 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.39 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.39 |
| ▸ | IMPDH2 | P12268 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | NFATC1 | O95644 | 2/20 | 0.38 |
| ▸ | GSK3B | P49841 | 2/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27981067 | 0.78 | MAPT (0.48) | MAPTLMNAERN1QDPRRPS6KA3 | |
| SCHEMBL28019150 | 0.74 | FYN (0.44) | MAPTLMNAERN1QDPRRPS6KA3 | |
| SCHEMBL13907315 | 0.72 | IMPDH2 (0.57) | MAPTLMNARPS6KA3NOTUMIMPDH2 | |
| SCHEMBL30084946 | 0.72 | IMPDH2 (0.57) | MAPTLMNARPS6KA3NOTUMIMPDH2 | |
| SCHEMBL26259778 | 0.71 | PARP10 (0.47) | MAPTLMNANOTUMIMPDH2HSD17B10 | |
| SCHEMBL23996421 | 0.70 | IMPDH2 (0.55) | MAPTLMNARPS6KA3NOTUMIMPDH2 | |
| SCHEMBL25862396 | 0.70 | MAPT (0.58) | MAPTLMNAQDPRCDC7NOTUM | |
| SCHEMBL1423606 | 0.70 | IDO1 (0.51) | MAPTLMNARPS6KA3NOTUMHSD17B10 | |
| SCHEMBL1423704 | 0.70 | ALDH1A1 (0.50) | MAPTLMNAERN1NOTUMHSD17B10 | |
| SCHEMBL1423922 | 0.70 | NPC1 (0.46) | MAPTLMNAERN1CDC7RPS6KA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11053267-B2 | Electrochromic compound, electrochromic composition, and display element | RICOH COMPANY, LTD. (JP) | 2021-07-06 | — | — | US | disclosed |
| US-11053267-B2 | Electrochromic compound, electrochromic composition, and display element | RICOH COMPANY, LTD. (JP) | 2021-07-06 | — | — | US | disclosed |
| US-20200216478-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | SAGISAKA TOSHIYA (JP) | 2020-07-09 | — | — | US | disclosed |
| US-20200216478-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | SAGISAKA TOSHIYA (JP) | 2020-07-09 | — | — | US | disclosed |
| US-10626133-B2 | Electrochromic compound, electrochromic composition, and display element | RICOH COMPANY, LTD. (JP) | 2020-04-21 | — | — | US | disclosed |
| US-10626133-B2 | Electrochromic compound, electrochromic composition, and display element | RICOH COMPANY, LTD. (JP) | 2020-04-21 | — | — | US | disclosed |
| US-20190031694-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | SAGISAKA TOSHIYA (JP) | 2019-01-31 | — | — | US | disclosed |
| US-20190031694-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | SAGISAKA TOSHIYA (JP) | 2019-01-31 | — | — | US | disclosed |
| US-10093693-B2 | Electrochromic compound, electrochromic composition, and display element | RICOH COMPANY, LTD. (JP) | 2018-10-09 | — | — | US | disclosed |
| EP-2914608-B1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | RICOH CO LTD (JP) | 2017-01-04 | — | — | EP | disclosed |
| EP-2914608-B1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | RICOH CO LTD (JP) | 2017-01-04 | — | — | EP | disclosed |
| US-20150274761-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | RICOH COMPANY, LTD. (JP) | 2015-10-01 | — | — | US | disclosed |
| US-20150274761-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | RICOH COMPANY, LTD. (JP) | 2015-10-01 | — | — | US | disclosed |
| US-20150274761-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | RICOH COMPANY, LTD. (JP) | 2015-10-01 | — | — | US | disclosed |
| EP-2914608-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | Ricoh Company, Ltd. (JP) | 2015-09-09 | — | — | EP | disclosed |
| CN-104768960-A | Electrochromic compound, electrochromic composition, and display element | RICOH CO LTD | 2015-07-08 | — | — | CN | disclosed |
| WO-2014069675-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | RICOH COMPANY, LTD. (JP) | 2014-05-08 | — | — | WO | disclosed |
| WO-2014069675-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | RICOH COMPANY, LTD. (JP) | 2014-05-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190031694-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | ANTXR2, SCN11A, H1-4 | MAPT 4400/4885LMNA 3656/4885ERN1 2123/4885 |
| US-20150274761-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | XPO7, F7, RPS4X | MAPT 4439/4885LMNA 3649/4885ERN1 1886/4885 |
| US-10626133-B2 | Electrochromic compound, electrochromic composition, and display element | ANTXR2, SCN11A, H1-4 | MAPT 4400/4885LMNA 3656/4885ERN1 2123/4885 |
| US-20200216478-A1 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT | SCN11A, H1-10, H1-2 | MAPT 4486/4885LMNA 3901/4885ERN1 2101/4885 |
| US-11053267-B2 | Electrochromic compound, electrochromic composition, and display element | SCN11A, H1-10, H1-2 | MAPT 4486/4885LMNA 3901/4885ERN1 2101/4885 |
| US-10093693-B2 | Electrochromic compound, electrochromic composition, and display element | XPO7, F7, RPS4X | MAPT 4464/4885LMNA 3665/4885ERN1 1757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.